Deals

Meer deals, pagina 40764

Elke deal hieronder heeft 13–97% korting. Prijzen worden real-time gesynchroniseerd van geverifieerde winkels.

Shenma Industrial Co., Ltd. (600810.SS): Canvas Business Model
-22%

Shenma Industrial Co., Ltd. (600810.SS): Canvas Business Model

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Shenma Industrial Co., Ltd. (600810.SS): BCG Matrix [Dec-2025 Updated]
-22%

Shenma Industrial Co., Ltd. (600810.SS): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Shenma Industrial Co., Ltd. (600810.SS) DCF Valuation
-40%

Shenma Industrial Co., Ltd. (600810.SS) DCF Valuation

dcfmodeling.comPLPL
PLN 15,00PLN 25,00
Shenma Industrial Co., Ltd. (600810.SS): PESTLE Analysis [Dec-2025 Updated]
-22%

Shenma Industrial Co., Ltd. (600810.SS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Shenma Industrial Co., Ltd. (600810.SS): Marketing Mix Analysis
-22%

Shenma Industrial Co., Ltd. (600810.SS): Marketing Mix Analysis

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Shenma Industrial Co., Ltd. (600810.SS): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Shenma Industrial Co., Ltd. (600810.SS): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Shenma Industrial Co., Ltd. (600810.SS): VRIO Analysis
-22%

Shenma Industrial Co., Ltd. (600810.SS): VRIO Analysis

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Shenma Industrial Co., Ltd. (600810.SS): SWOT Analysis [Dec-2025 Updated]
-22%

Shenma Industrial Co., Ltd. (600810.SS): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Orient Group Incorporation (600811.SS): BCG Matrix [Dec-2025 Updated]
-22%

Orient Group Incorporation (600811.SS): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Orient Group Incorporation (600811.SS): Ansoff Matrix
-22%

Orient Group Incorporation (600811.SS): Ansoff Matrix

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Orient Group Incorporation (600811.SS): Canvas Business Model
-22%

Orient Group Incorporation (600811.SS): Canvas Business Model

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Orient Group Incorporation (600811.SS) DCF Valuation
-40%

Orient Group Incorporation (600811.SS) DCF Valuation

dcfmodeling.comPLPL
PLN 15,00PLN 25,00
Orient Group Incorporation (600811.SS): PESTLE Analysis [Dec-2025 Updated]
-22%

Orient Group Incorporation (600811.SS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Orient Group Incorporation (600811.SS): Marketing Mix Analysis
-22%

Orient Group Incorporation (600811.SS): Marketing Mix Analysis

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Orient Group Incorporation (600811.SS): SWOT Analysis [Dec-2025 Updated]
-22%

Orient Group Incorporation (600811.SS): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Orient Group Incorporation (600811.SS): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Orient Group Incorporation (600811.SS): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
North China Pharmaceutical Company Ltd. (600812.SS): BCG Matrix [Dec-2025 Updated]
-22%

North China Pharmaceutical Company Ltd. (600812.SS): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
North China Pharmaceutical Company Ltd. (600812.SS): Ansoff Matrix
-22%

North China Pharmaceutical Company Ltd. (600812.SS): Ansoff Matrix

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
Orient Group Incorporation (600811.SS): VRIO Analysis
-22%

Orient Group Incorporation (600811.SS): VRIO Analysis

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
North China Pharmaceutical Company Ltd. (600812.SS): Canvas Business Model
-22%

North China Pharmaceutical Company Ltd. (600812.SS): Canvas Business Model

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
North China Pharmaceutical Company Ltd. (600812.SS): PESTLE Analysis [Dec-2025 Updated]
-22%

North China Pharmaceutical Company Ltd. (600812.SS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
North China Pharmaceutical Company Ltd. (600812.SS): Marketing Mix Analysis
-22%

North China Pharmaceutical Company Ltd. (600812.SS): Marketing Mix Analysis

dcfmodeling.comPLPL
PLN 7,00PLN 9,00
North China Pharmaceutical Company Ltd. (600812.SS) DCF Valuation
-40%

North China Pharmaceutical Company Ltd. (600812.SS) DCF Valuation

dcfmodeling.comPLPL
PLN 15,00PLN 25,00
North China Pharmaceutical Company Ltd. (600812.SS): VRIO Analysis
-22%

North China Pharmaceutical Company Ltd. (600812.SS): VRIO Analysis

dcfmodeling.comPLPL
PLN 7,00PLN 9,00